News | September 29, 2010

First Breast Cancer Patient to Receive Treatment Using Gated RapidArc

September 29, 2010 — A 51-year-old breast cancer patient from Switzerland has become the first person in the world to be treated using Gated RapidArc, which makes it possible to monitor patient breathing and compensate for tumor motion while quickly delivering radiotherapy during a continuous rotation around the patient.

This development from Varian Medical Systems enables the use of RapidArc radiotherapy technology in combination with respiratory gating – a process of turning the beam on and off in synchrony with the patient’s breathing. This technique increases the precision of treatment delivery by compensating for tumor motion.

The treatment took place at the Istituto Oncologico della Svizzera Italiana (IOSI) radiation oncology unit in Bellinzona, a public comprehensive cancer center serving 330,000 inhabitants in southern Switzerland and part of Ente Ospedaliero Cantonale at San Giovanni Hospital.

Dr. Giorgia Nicolini, medical physicist at IOSI, said, “This is a very fast and straightforward procedure for the patient, who doesn’t speak the local language, Italian, but in any case has found it very easy to follow instructions for gating. She has been fully cooperative, and the part of the treatment time taken up by breathing management is decreasing after the first sessions. She also appreciates having to spend less time on the treatment couch.”

The hospital has used breath-hold gating as part of the treatment procedure for all left breast cancer patients since 2005 to better spare the heart and lung from exposure during radiotherapy treatment. Prior to Gated RapidArc, conventional seven-field gated intensity-modulated radiation therapy (IMRT) treatments would have taken 15 minutes to deliver. Using two-arc Gated RapidArc, the treatment is concluded in around four minutes.

Dr. Nicolini said clinicians at IOSI compared RapidArc and IMRT treatment plans for the patient and decided RapidArc offered the better opportunity to spare nearby organs from exposure and target the tumor.

“The use of two partial arcs enables us to shape a better dose distribution and do a better job of sparing the opposite breast,” said Antonella Richetti, M.D., head of the IOSI Radiation Oncology Department. In addition, RapidArc enabled the dose to be delivered using fewer than half the dose monitor units needed for an equivalent conventional seven-field IMRT treatment.

“We are now using Gated RapidArc to treat all left-sided breast cancer patients when there is a need to include the supraclavicolar and/or internal mammary chain lymph nodes, or when chest wall anatomy will affect the dose to organs we want to protect,” said Dr. Nicolini. “We are also planning to use the technique for lung and other thoracic and abdominal tumors when suitable.”

Gated RapidArc is a standard feature on the new TrueBeam system and is available as an option or upgrade on the Trilogy and Clinac iX accelerators from Varian.

For more information: www.varian.com

Related Content

Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
New U.S. Tariffs on Chinese Goods Include Imaging Equipment
News | Radiology Business | June 15, 2018 | Jeff Zagoudis, Associate Editor
The Office of the U.S. Trade Representative (USTR) released the much-anticipated list of Chinese-manufactured goods...
California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
How AI and Deep Learning Will Enable Cancer Diagnosis Via Ultrasound

The red outline shows the manually segmented boundary of a carcinoma, while the deep learning-predicted boundaries are shown in blue, green and cyan. Copyright 2018 Kumar et al. under Creative Commons Attribution License.

News | Ultrasound Imaging | June 12, 2018 | Tony Kontzer
June 12, 2018 — Viksit Kumar didn’t know his mother had...
Overlay Init